Fabbio Patrick 4
4 · Protara Therapeutics, Inc. · Filed Jan 30, 2023
Insider Transaction Report
Form 4
Fabbio Patrick
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-01-30+300,000→ 300,000 totalExercise: $3.14Exp: 2033-01-29→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]One-fourth of the shares shall vest on January 30, 2024 and the remainder of the shares will vest in a series of thirty-six successive equal monthly installments measured from January 30, 2024, subject to the Reporting Person's Continuous Service (as defined in the Company's 2020 Inducement Plan) with the Issuer through each such vesting date.